A new gel aims to fade dark Spots—Will it deliver a brighter complexion?

NCT ID NCT07769268

NEW Recruiting now Symptom relief Sponsor: Brainfarma Industria Química e Farmacêutica S/A Source: ClinicalTrials.gov ↗

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This trial tests whether a depigmenting gel cream called Blancy Pro can reduce facial hyperpigmentation, including dark spots and melasma. Forty women aged 30 to 60 will apply the product daily for 90 days. Researchers will measure skin lightening using a colorimeter and clinical assessments to see if the cream improves skin appearance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blancy Pro, a depigmenting gel cream applied to the face
What this could lead to: If effective, this cosmetic product could offer a non-prescription option to visibly lighten dark spots and melasma, improving skin tone and appearance.
What could go wrong: This is a small, early-stage cosmetic study without a control group, so results may not prove the product works better than placebo. Skin irritation or incomplete lightening are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERPIGMENTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperpigmentation hyperpigmentation of the skin lentigo Melanosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERPIGMENTATION MELASMA (FACIAL MELASMA)

Contacts and locations

Locations

Grupo Medcin
RECRUITING

Osasco, São Paulo, 06023-070, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.